Clinical trial
Best PREDICTive FactOR of Overall Survival Among Geriatric Assessment Tools and Disease Related Factors in Elderly Patients With High Risk Myelodysplastic Syndromes.
NCT02689622 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Best PREDICTive FactOR of Overall Survival Among Geriatric Assessment Tools and Disease Related Factors in Elderly Patients With High Risk Myelodysplastic Syndromes.
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 20, 2016
- Completion date
- January 31, 2020
- Enrollment
- 157 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.